839708-50-8

Usage

Uses

Used in Pharmaceutical Research:
5-Pyrimidinecarboxaldehyde, 2-chloro-4-(methylamino)is used as a key intermediate in the development of drugs and agrochemicals. Its unique structure and functional groups enable the synthesis of various heterocyclic compounds with potential applications in medicine.
Used in Organic Synthesis:
As a versatile chemical compound, 5-Pyrimidinecarboxaldehyde, 2-chloro-4-(methylamino)is employed as a building block in organic synthesis for creating new compounds with diverse properties and applications.
Used in Materials Science:
5-Pyrimidinecarboxaldehyde, 2-chloro-4-(methylamino)has potential applications in the field of materials science, where its unique structure and properties can be utilized to develop advanced materials with specific characteristics.

Upstream product

• 205672-24-8 5-bromo-2-chloro-N-methyl-pyrimidin-4-amine 
• 839708-49-5 (2-chloro-5-vinylpyrimidin-4-yl)methylamine 
• 1428760-93-3 (2-chloro-4-(methylamino)pyrimidin-5-yl)methanol 
• 1428760-92-2 ethyl 2-chloro-4-(methylamino)pyrimidine-5-carboxylate 
• 51940-64-8 ethyl 2,4-dichloropyrimidine-5-carboxylate 
• 1428760-91-1 ethyl 2,4-dioxohexahydropyrimidine-5-carboxylate 
• 92264-75-0 2,4-dioxohexahydropyrimidine-5-carboxylic acid 

Downstream Products

• 839708-51-9 N-{3-[(2-chloro-4-methylaminopyrimidin-5-ylmethyl)amino]-4-methylphenyl}-3-trifluoromethylbenzamide 
• 1428760-94-4 4-(3-chloro-4-(2-chloro-8-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-6-yl)phenyl)-N-methylpicolinamide 
• 1428759-62-9 C₃₃H₃₂ClN₇O₂ 
• 839708-52-0 N-(3-(7-chloro-1-methyl-2-oxo-1,4-dihydropyrimido[4,5-d]-pyrimidin-3(2H)-yl)-4-methylphenyl)-3-(trifluoromethyl)benzamide 

Relevant academic research and scientific papers

8-ETHYL-6-(ARYL)PYRIDO [2,3-D]PYRIMIDIN-7(8H) -ONES FOR THE TREATMENT OF NERVOUS SYSTEM DISORDERS AND CANCER

Provided herein are PAK inhibitors and methods of utilizing PAK inhibitors for the treatment of CNS disorders such as neuropsychiatric disorders or neurofibromatosis. Also described herein are methods of utilizing PAK inhibitors for the treatment of cancer.

COMPOUNDS THAT MAINTAIN PLURIPOTENCY OF EMBRYONIC STEM CELLS

The present invention relates to methods and compositions for culturing embryonic stem (ES) cells. The methods relate to growing the ES cells in the presence of small molecules of formula (I) that maintain the pluripotency/self-renewal of the cells withou